Garner Insights has added a new report titled, Global Primary Progressive Multiple Sclerosis Treatment Market Professional Report 2026 to its vast repository of research reports. This is a thorough report focused on the current and future prospects of the Global Primary Progressive Multiple Sclerosis Treatment Market. The report offers data of previous years along with an in-depth analysis from 2020 to 2026 on the basis of revenue (USD Billion) Continue reading →

Cyclists participating in Bike MS 2019 ride. // Photo by Kent Ruby Photography The woman with progressive multiple sclerosis who struggles to button her shirt in the morning, yet is determined to stand up and dance at her granddaughters wedding Continue reading →

NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics (http://www.inflam.com), a privately held company developing therapies for prevalent, degenerative diseases, reported that data analyses published today in Nature Communications https://www.nature.com/articles/s41467-020-18528-z showed that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used to treat HIV for more than 30 years, reduced their risk of developing type 2 diabetes by 33%, a highly statistically significant result (p < 0.0001). Nineteen coauthors from leading institutions examined data from 128,861 patients over 17 years from five large national health insurance databases to assess the relationship between treatment with NRTIs and development of type 2 diabetes. The study also found that lamivudine, a commonly used NRTI, inhibited inflammasome activation, implicated as a key driver of type 2 diabetes, restored insulin sensitivity in type 2 diabetic human cells and prevented development of insulin resistance in non-diabetic human cells Continue reading →

Michael Costanzo, a Colorado farmer diagnosed with multiple sclerosis in 2016, has a well-honed ritual: Every six months, he takes an IV infusion of a medicine, Rituxan, to manage his disease, which has no cure. Then he figures out how to manage the bill, which costs thousands of dollars Continue reading →

Findings of a recent analysis indicated frozen fecal material from universal donors may be related to a higher rate of clinical remission among patients with inflammatory bowel disease (IBD), especially for Crohn disease. Continue reading →

Integration is a loaded word in the health and human service field.And the implications are dependent on where you sit.For payers and health plans, integration means a whole person approach to care coordination.The ideal model hasmedical, behavioral, and social needs addressed together in a system that has seamless consumer services, integrateddata at the consumer level, and alignmentof financial incentives.From the provider organization perspective, the question is to determine, even if your organization cant be the entire solution, how to create (through new capability development, mergers, or collaboration) a system with these characteristics. These perspectives on integration were the focus of our session, Best Practice Models For Collaborative Care: Coordination Between Health Plans & Provider Organizationsat our 2020OPEN MINDS Management Best Practices Institute. The session had the perspective of both a health plan executiveMargaret Kisliuk, behavioral health administrator at Partnership Health Plan of California (PHC), and two provider organization executivesJim Coffee, chief operating officer and deputy director at Cowlitz Family Health Center; and Susan Foster, chief medical officer at Hill Country Health and Wellness Center Continue reading →